Beginner's Mind

Are you part of the 70%? Vitamin D deficiency is a silent crisis affecting both the U.S. and Europe. The lack of this essential nutrient can lead to severe mental health issues, including depression and anxiety, due to its role in serotonin production. Physical health is also at risk, with increased chances of respiratory issues and even cancer. In this eye-opening episode, we delve into the Huberman Lab Podcast, where Dr. Andrew Huberman and his guest Dr. Rhonda Patrick, discuss the alarming rates and severe health consequences of Vitamin D deficiency. Who are Dr. Andrew Huberman and Dr. Rhonda Patrick? Dr. Andrew Huberman is a renowned neuroscientist and professor at Stanford University. His guest, Dr. Rhonda Patrick, is an expert in nutritional health. Together, they unpack the science behind Vitamin D, its crucial role in our body, and why you should be concerned about your Vitamin D levels. Who Needs to Watch This? If you care about your mental and physical health, this episode is a must-watch. Whether you're in the U.S. or Europe, young or old, the information here is vital for everyone. What You'll Learn: Timestamps: (01:22) Introduction to Vitamin D's Importance (01:46) Vitamin D and Skin Color (03:17) Vitamin D Deficiency in the Population (04:49) Vitamin D and Gene Regulation (04:59) Vitamin D and Serotonin (07:15) Importance of Testing Vitamin D Levels (07:27) Vitamin D Supplementation Dosage Take Control of Your Health Don't be part of the statistics. Consult your physician or pharmacy today to get your Vitamin D levels checked. Your health is in your hands. 🎧 Don't forget to leave us a review and share this episode with your network! 🎧 Subscribe for more exclusive content from industry leaders. 🎧 Special thanks to our sponsors. Check out the companies that make this podcast possible! Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Did you know that the fight against climate change is shaping up to be the biggest business opportunity since the rise of the internet? Imagine a multi-trillion-dollar market waiting to be tapped! Yair Reem and his €300M venture capital firm, Extantia Capital, are not just imagining it—they're building it. Tune in to discover how you can be part of this green gold rush! 🎙️ What's in the Episode: 1️⃣ The Urgency of Climate Change: Yair discusses why climate change is not just an environmental issue but a ticking time bomb that affects every sector of the economy. 2️⃣ The Role of Venture Capital: Learn how Extantia Capital is more than just a fund—it's a €300M platform that unites mission-driven entrepreneurs, scientists, and business leaders to advance the transition to a greener future. 3️⃣ The Multi-Trillion Dollar Opportunity: Yair shares insights into how the fight against climate change creates unprecedented business opportunities, potentially even 100x bigger than the internet revolution. 👨‍💼 About Yair Reem: Yair Reem is more than an investor; he's a builder. From childhood Legos to Electrical Engineering and co-founding Extantia Capital, his path is fueled by a drive to make impact. With experience on both sides of investment, he knows what makes a firm succeed. His motto, "Do well by doing good," shows his belief that profit and impact can coexist. 💡 LINKS TO MORE CONTENT Host: Speaker 📌 Quotes: (21:10) "The technologies we have today can only take us halfway to net zero emissions. There's a lot of technology that still needs to be developed and scaled to make it ready for the mass market." (23:38) "To bridge the 50% gap in fighting climate change, we need to deploy capital to motivate scientists to develop new solutions and companies to scale those solutions." (57:58) "When we look at the intersection of public and private sectors, we see that regulators are essential for both basic research and for making certain industries profitable where they currently aren't. But the key question remains: How do we ensure that these profits are reinvested to drive down costs and improve processes, rather than being siphoned off for other uses?" (1:07:08) "The worst time to raise money is when you need 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify What Your CPA Wants You to Know A podcast for entrepreneurs! We are a husband and wife team running our CPA firm... Listen on: Apple Podcasts Spotify Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

"Are you tired of the long, winding road of drug discovery, full of dead-ends and costly detours? Do you wish there was a more efficient way to navigate the complex landscape of pharmaceutical R&D? In this episode, we bring you the solution that promises to be the 'Google Maps' for drug discovery. Samantha Dale Strasser, PhD, CSO and co-founder of Pepper Bio, shares her revolutionary approach to drug discovery that's already making waves in the healthcare industry. 👉 Don't miss out on this game-changing conversation. Click below to watch the full episode or listen to the entire podcast. 🎉 Special thanks to our sponsors for making this episode possible. Join my newsletter Christian Soschner Samantha Dale Strasser Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

In this special episode, we bring you exclusive insights from Warren Buffett and Charlie Munger, straight from the Berkshire Hathaway 2023 Shareholder Meeting. They tackle the age-old investor's dilemma: How to balance short-term profits with long-term sustainability. Whether you're a retail investor or running a multi-billion dollar fund, this episode is packed with wisdom you won't want to miss. 🎧 Don't forget to leave us a review and share this episode with your network! 🎧 Subscribe for more exclusive content from industry leaders. 🎧 Special thanks to our sponsors. Check out the companies that make this podcast possible! Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Is revolutionizing patient care through biotechnology an ambitious dream, or is it the future of medicine? Dr. Daniel Vitt, a leading figure in the biotech world, challenges the status quo and brings a fresh perspective to these questions. Dr. Daniel Vitt is the CEO of Immunic Therapeutics, a company at the forefront of developing groundbreaking treatments for chronic inflammatory and autoimmune diseases. With a background in molecular biology and a passion for innovation, he is steering Immunic towards a future where patients have more effective and safer treatment options. In this episode, we delve into: • The visionary approach of Immunic Therapeutics in treating multiple sclerosis and leaky gut. • The challenges and triumphs of bridging European and American biotech markets. • The role of serendipity in scientific discovery and innovation. • The future of Immunic: clinical trials, stock prices, and global expansion. • Daniel’s three key lessons for anyone daring to start their own company in the biotech industry. • Don't miss out on this insightful conversation. Subscribe to our channel and join us in exploring the future of biotech with Dr. Daniel Vitt. 💡 LINKS TO MORE CONTENT Youtube Christian Soschner: Today’s speaker is Dr. Daniel Vitt: 📖 Memorable Quotes: (00:02:23) "Every morning, when I go to work, I enjoy being part of an industry that improves patients' lives." (00:05:26) "Understanding the key and lock principle in biology is our path to curing diseases." (00:24:49) "Serendipity means you're searching for a needle in a haystack, but you find something unexpected and even more valuable." (01:13:23) "If you are early and have a big vision, you can succeed easily." (01:32:35) "Expect the unexpected and be prepared. Adaptability is key in our rapidly changing industry." ⏰ Timestamps: (00:01:15) Unveiling the Future of Patient Care (00:05:26) Decoding the Key-Lock 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify What Your CPA Wants You to Know A podcast for entrepreneurs! We are a husband and wife team running our CPA firm... Listen on: Apple Podcasts Spotify Buzzsprout - Let's get your podcast launched! Start for FREE Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Ever wondered how AI is revolutionizing drug discovery? Dive into this insightful conversation with Marco Schmidt, the brilliant mind behind Biotx.ai. As the CSO, Marco has been at the forefront of leveraging AI and genetics to predict drug success. In this clip, he shares his journey from data interpretation to predictive statistics, the inception of Biotx.ai, and the transformative impact of artificial intelligence on drug development. Discover the future of medicine and the role of AI in shaping it. If you find this intriguing, don't forget to like, comment, subscribe, and share. Let's drive the conversation forward! Full episode Join my newsletter Check out the sponsors to support the show Full Episode Christian Soschner Marco Schmidt Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Ever feel like your emotions are driving your investment decisions? You're not alone. It's a wild ride in the investment world, and it's all too easy to let our emotions take the wheel. But here's a secret from two of the greatest investors of our time, Warren Buffett and Charlie Munger. In this clip from the 2023 Berkshire Hathaway Shareholder Meeting, they spill the beans on how they keep their emotions in check. They've made their fair share of bad investment decisions, but they've never let their emotions dictate their choices. This is a game-changer, folks. The market is a roller coaster, and if we let fear and greed take over, we're in for a bumpy ride. But Buffett and Munger remind us to stay cool, calm, and collected. Investing isn't about making a quick buck or panicking when things go south. It's about making smart choices based on solid research and sticking to your guns, even when the market is doing somersaults. So the next time you feel your heart racing or your palms sweating over your investments, take a deep breath and channel your inner Buffett. Keep those emotions in check, stay disciplined, and keep your eyes on the prize. Check out the clip to hear it straight from Buffett and Munger. And don't forget to share it with your fellow investors. The more we learn, the better we can navigate the wild world of investing. Youtube Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Climate change is here, and it's urgent. In this clip, Dr. Kimberley R. Miner, a Climate Scientist at NASA, unveils her top three actions to combat climate change. From halting carbon emissions to preserving biodiversity, Kimberley's insights are a must-listen for anyone concerned about our planet's future. Tune in to discover what we can do today to safeguard tomorrow. Don't forget to subscribe for more insights! This is a conversation you won't want to miss. Join my newsletter Check out the sponsors to support the show Full Episode Christian Soschner Kimberley Miner Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

"Believe in the team, invest the money." This is Philipp Baaske, founder and CEO of NanoTemper Technologies. His company, a global biotech powerhouse, is on a mission to create a world where every disease is treatable. Philipp's journey from a small Bavarian village to leading a global team of 240 is inspiring. His company now generates over 35 million in annual revenue. His secret? Start small, dream big, and invest profits back into the business. In this clip, Philipp shares his insights. He talks about the importance of angel investors in startups. They're not just financial backers. They're partners. They're believers in the team and the vision. His story echoes the audacity of tech giants. Like Bill Gates selling an operating system before it was fully developed. Like Steve Jobs' relentless focus on customer experience at Apple. Join us for this enlightening conversation. Philipp offers a rare glimpse into the world of startups. He talks about the dynamics between startups and their angel investors. He emphasizes the importance of trust. Click play. Dive into the world of startups and angel investing. Don't forget to subscribe for more insights! This is a conversation you won't want to miss. Join my newsletter Check out the sponsors to support the show Full Episode Christian Soschner Philipp Baaske Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Is investing in climate tech just a trend, or is it the future of venture capital? Doerte Hirschberg, a leading figure in the VC world, challenges the status quo and brings a fresh perspective to these questions. Doerte Hirschberg is the co-founder and managing partner of Climentum Capital, a venture capital firm that focuses on climate tech investments. With a background in traditional investments, she has transitioned into the climate tech space, bringing with her a wealth of knowledge and a unique perspective on the intersection of business viability and environmental sustainability. In this episode, we delve into: The transition from traditional investments to climate tech. The intersection of climate tech and business viability. The role of women in venture capital and the gender gap in VC investment. The role of regulations and capital in shaping Europe's climate tech future. Balancing work and family life in the demanding world of venture capital. Don't miss out on this insightful conversation. Subscribe to our channel and join us in exploring the future of climate tech investing with Doerte Hirschberg. 💡 LINKS TO MORE CONTENT Youtube Christian Soschner Today’s speaker is Doerte Hirschberg 📖 Memorable Quotes: (04:49) "Installing solar and investing in energy-saving technologies make sense from a business case point of view." (15:04) "Climate change and CO2 emissions are measurable impact topics, making our fund's impact target as credible as our financial ones." (35:04) "In the VC investment field, you mostly have male teams or one woman, especially in the industrial sector." (39:17) "The traditional venture capital game is about the winner. Women, making up 50% of consumers, can see many trends and insights more clearly." (01:06:37) "My aspiration is a transition towards a more sustainable industry and society, reducing extreme poverty and maintaining Earth as a livable place." ⏰ Timestamps: (00:01:00) Initiating 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify What Your CPA Wants You to Know A podcast for entrepreneurs! We are a husband and wife team running our CPA firm... Listen on: Apple Podcasts Spotify The LSG2G Partners Experts in Life Science Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Failure is a common theme among entrepreneurs, but it's how you handle it that sets you apart. In this video, you'll hear from NVIDIA's CEO, Jensen Huang, t how he overcame failure and achieved success. He has weathered the storm of failure, only to emerge stronger and more determined leading NVIDIA to a 1 trillion dollar market cap in 2023. On this channel, we're all about unearthing these inspiring stories and delivering motivational content that fuels your ambition. Tune in to this episode to gain invaluable insights and ignite your drive to conquer your own entrepreneurial journey. Youtube Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Join Tobias Silberzahn, a Partner at McKinsey's Berlin office and a leader in the global Health Tech Network, as he delves into the crucial role of lifestyle habits in maintaining mental health and well-being. In this enlightening talk, Tobias discusses the importance of sleep, nutrition, mobility, fitness, and purpose, providing practical advice that viewers can apply in their daily lives. He also explores the biochemical processes involved and the effects of sleep deprivation and lack of movement on anxiety levels. Don't miss this opportunity to learn from a leading expert in healthcare innovation and digital transformation. Join my newsletter Check out the sponsors to support the show Full Episode Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

In a world on the brink of climate catastrophe, one woman stands at the forefront of scientific discovery and action. "We found the highest microplastics in the world on Mount Everest, a sad Guinness World Record to hold," reveals Dr. Kimberley R. Miner in this gripping episode. Dr. Miner is a Climate Scientist and Program Manager at the NASA Jet Propulsion Lab, a Guinness World Record holder, and an adventurer who has braved the extreme environments of the North Pole, Antarctica, and Mt. Everest. Her groundbreaking research on climate risks has garnered international recognition, with features in the BBC, NYT, and GQ. This episode takes you on a journey from the icy slopes of Everest to the cutting-edge labs of NASA. It delves into the pressing issues of climate change, the surprising discovery of microplastics at extreme altitudes, the role of art in science communication, and the importance of diverse perspectives in tackling global challenges. It also offers a sneak peek into Kimberley's upcoming book on how younger generations can plan for climate change. This is a riveting exploration of our planet's most pressing issue, through the eyes of a scientist who has literally seen it from top to bottom. A must-listen for those seeking to understand the real-world implications of climate change and the solutions that science and innovation can offer. 💡 LINKS TO MORE CONTENT Youtube Christian Soschner: Today’s speaker is Kimberley R. Miner: 📖 Memorable Quotes: (00:07:00) "We're changing Earth's dynamics faster than ever before." (00:15:36) "We can create a healthier, more natural planet with advanced tools." (00:24:15) "Forecasting changes due to climate change is a monumental task." (00:40:39) "Stop releasing carbon, dedicate land to wilderness, and engage in conversations about our planet's reality." ⏰ Timestamps: (0:00) Kickoff (4:53) Current Status of Climate Change: A Global Perspective (8:22) The Sixth Mass Extinction: Biodiversity Loss and Ecosystem Collapse (11:11) Unveiling the Power of Emit: NASA's Methane Tracker (16:07) The Journey to Becoming a Climate Scientist at NASA (21:03) The Arctic Methane Challenge: A Collaborative Effort (22:22) Unraveling the Climate Crisis - Microbes, Methane and Melting Permafrost (25:29) The Immediacy of Climate Change - A Matter of Decades (29:43) The Invisible Threat - Toxic Chemicals in a Changing Climate (33:30) Unveiling the Highest Microplastics on Mount Everest (36:30) The Top Three Actions to Combat Climate Change (42:47) The Role of Biodiversity in Addressing Climate Crisis 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Join us as we dive into a captivating discussion with Brian Feroldi, a financial educator and author, who simplifies the complex world of investing. In this episode, Brian shares his insights on why the stock market goes up, the power of cost averaging, and his biggest investment mistake. Subscribe and learn how to navigate the financial world with ease. Join my newsletter Check out the sponsors to support the show Full Episode Book Mentions: "Rich Dad, Poor Dad." Link: https://amzn.to/3zuC0wr "One Up on Wallstreet" Link: https://amzn.to/3zxSkwv "Why Does the Stock Market Go Up" Link: https://amzn.to/3M8i6Nb Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Dive into the untold stories of PayPal's meteoric rise! This video takes you back to the 90s, a time when the internet was just beginning to transform business. It was a challenging era, with limited access to information and a lack of understanding about the potential of the internet. Fast forward to today, and we see the fruits of the labor of PayPal's founders. They not only survived the dot-com bubble but also thrived, becoming some of the most influential figures in the tech industry. How did they do it? What lessons can we learn from their journey? This video explores how PayPal's founders drove 21st-century innovation and entrepreneurship, forming, funding, and advising some of the leading companies of our era, including Tesla, Facebook, YouTube, Space X, Yelp, Palantir, and LinkedIn. Tune in to discover the secrets behind their success, gain unprecedented insights from hundreds of interviews and thousands of pages of internal material, and learn how you can apply these lessons to your own entrepreneurial journey. Don't forget to like, share, and subscribe for more inspiring content! Join my newsletter Check out the sponsors to support the show Full Episode Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Welcome back to another episode of Memorable Moments. Today's spotlight is on the conversation with Sebastian Mallaby, acclaimed author of 'The Power Law'. Venture capital, often a labyrinth of jargon and complex concepts, is made accessible through Mallaby's unique storytelling approach. This episode reveals the meticulous process behind his writing, showcasing the comprehensive research and interviewing methods that shape his work. It's a testament to the power of storytelling in making even the most complex subjects engaging. The journey continues with the uncovering of the stories behind venture capital. These narratives, brought to life through Mallaby's exceptional storytelling, offer a fresh perspective on the world of venture capital. Curiosity about the evolution of venture capital or a simple appreciation for great storytelling makes this episode a must-listen. This memorable moment with Sebastian Mallaby invites listeners to immerse themselves in the fascinating world of venture capital. Listen now, and let the journey begin. Join my newsletter Check out the sponsors to support the show Full Episode Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Entrepreneurs and investors often grapple with the complexities of the biotech industry. The high risk associated with drug development, coupled with the intricate regulatory environment, can make biotech investments seem daunting. Moreover, the need for substantial capital and the long timeline for potential returns can further complicate the investment decision. This clip provides a comprehensive overview of the biotech investment landscape, offering valuable insights from industry experts. By watching this clip, you will understand the challenges and opportunities in biotech investments, learn about the importance of patient capital, and discover strategies to mitigate risks. This knowledge can empower you to make informed investment decisions, potentially leading to high returns and contributing to advancements in healthcare and medicine. 📖 Quote: (04:44) And we would have lost all of our money. And that's what investors have to go through every day. And so we're trying to put it in language so that every Joe understands that if you price fix these drugs, you will stop the cures of the future. ⏰ Timestamps 00:00:00 "High Stakes in Biotech Investing" 00:01:24 "Standing Up for Science" 00:02:36 "Price Fixing Stifles Innovation" Watch the full video: 💡 LINKS TO MORE CONTENT Podcast: https://beginnersmind.buzzsprout.com/779930/12959749 Rich Masters: https://www.linkedin.com/in/rimasters/ Christian Soschner: https://www.linkedin.com/in/christiansoschner/ Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Navigating the biotech industry's rapid advancements and complex regulations can be daunting. High-stakes investments and the pressure to innovate further add to the challenge. Rich Masters, the CMO of BIO (Biotechnology Innovation Organization), is a seasoned expert in this field. His role in organizing the BIO International Convention and his extensive industry experience equips him with unique insights to tackle these challenges. In this fantastic podcast episode, we delve into: 🔬 The behind-the-scenes experience of organizing and attending the BIO International Convention 2022 in San Diego. 🔬 Rich's journey to the helm of BIO as CMO and his vision for the organization. 🔬 The meticulous preparations for the upcoming BIO International Convention 2023 in Boston, anticipated to be a landmark event in the biotech calendar. 🔬 The innovative features and services introduced for the BIO International Convention 2023, including the BIO Podcast series and the BIO News platform. 🔬 Rich's perspective on the future of the biotech industry, discussing potential challenges and opportunities for 2024 and beyond. 💡 LINKS TO MORE CONTENT Youtube Christian Soschner: Rich Masters 📖 Memorable Quotes: (13:50) "The majority of biomedical and drug innovation investments fail... This ecosystem is crucial and needs protection." (15:00) "Developing a drug is an expensive process... Without investment, the engine of innovation stalls, we don't see new drugs on the market." (16:38) "If you price fix these drugs, you are going to stop the cures of the future." (20:01) "What we're witnessing worldwide is an attack from socialist-minded groups against intellectual property, our only asset." (26:18)"Our main focus may be on Washington, but we work closely with our International Biotech Association based in Brussels. We have numerous international partners." (29:09) "As the next pandemic looms, the question is, do we want all drug development concentrated in one country, or a viable drug development market in the West?" (42:12) "We can't continue to stifle innovation and science and then expect to create the next generation of cures... we're eliminating entire classes of diseases." (44:10) "Biotechnology 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify What Your CPA Wants You to Know A podcast for entrepreneurs! We are a husband and wife team running our CPA firm... Listen on: Apple Podcasts Spotify Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Navigating the investment landscape can be a daunting task. It's easy to feel like you're constantly making the wrong moves and not achieving your financial goals. This episode brings you the wisdom of legendary investor Mohnish Pabrai, who shares his insights on overcoming these hurdles and achieving success in investing. Here's what you can expect from this episode: By the end of this episode, you'll better understand how to navigate the investment landscape and make more informed decisions. So, tune in, take notes, and let's embark on this journey to financial growth together. Don't forget to share this episode with your friends and colleagues who might find it useful. And if you enjoyed this episode, please leave us a review. Your feedback helps us improve and reach more people like you. Youtube Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link

Are you tired of seeing the world struggle with global health crises? It's a harsh reality that many vaccine-preventable diseases continue to devastate vulnerable populations. But there's hope on the horizon! In this eye-opening episode, we dive deep into a conversation with Colin McCann, a key player at the International Vaccine Institute (IVI), who shares incredible insights into their innovative approach to combatting these health challenges. You'll discover the groundbreaking strategies and collaborative efforts reshaping how we develop and deliver life-saving vaccines to those who need them most. Don't miss out on this unique opportunity to learn about the future of global health and how the IVI is making a real difference. Click now to watch the full episode and get inspired! 💡 LINKS TO MORE CONTENT Youtube Christian Soschner: Colin McCann 📖 Memorable Quotes: (29:30) "IVI's role is to pick up challenges that the pharma industry would turn down, starting with comprehensive disease burden studies and surveillance to determine the true burden of neglected diseases." (40:02) "There's the great problem of the translational graveyard - we have lots of wonderful vaccine candidates sitting on shelves around the world collecting dust, instead of saving lives." (41:47) "European developers should realize that they could manufacture their vaccines in Africa, Latin America, or Asia and maintain profitability in doing so." (55:51) "Countries that are often in tension with each other are able to cooperate on vaccine development." (01:01:46) "By linking low & middle income countries together, they can train each other and build upon each other's abilities." (01:18:44) "IVI's proven model: developing a vaccine from evidence through licensure & delivery, takes a comprehensive approach." ⏰ Timestamps: (02:28) Vienna: The Hub for IVI's European Expansion (07:55) The Unconventional Path to Joining the International Vaccine Institute (11:09) Colin's journey: From wind turbine engineer to IVI member (17:51) Bridging the gaps in vaccine development and scaling (21:47) IVI's role in growing South Korea's biotech sector (28:31) IVI's Role in Addressing Unmet Vaccine Needs (35:56) 25 Minutes of Unfinished Business, hosted by Alex Brayshaw The reason I’ve created Unfinished Business is because I’m passionate about business... Listen on: Apple Podcasts Spotify Uranium Spotlight: Nuclear's Resurgence in a Clean Energy World A weekly podcast on uranium fuel market trends and its global energy impact. Listen on: Apple Podcasts Spotify What Your CPA Wants You to Know A podcast for entrepreneurs! We are a husband and wife team running our CPA firm... Listen on: Apple Podcasts Spotify Support the showDo you want to support the podcast team? Join the LSG2G Newsletter as a paying member: Link